Transactions
Deal Showcase
$125 Million
Joint Bookrunner
Follow-On
February 2023
More Transactions
$119 Million
Joint Bookrunner
Follow-On
October 2021
$150 Million
Joint Bookrunner
Follow-On
December 2023
$35 Million
Exclusive Financial Advisor
Series C Financing Led by MultiPlan Corporation
June 2022
Featured Insights
Articles
July 2026
Benchmarking the Prices of Desmoid Tumor Therapies: A Framework Based on Implied Reimbursement and Health Economic Value
Podcasts
July 2026
What Happens When Drug Pricing Meets Trade Policy? A Conversation with Ron Lanton
Featured Research
July 2026
Life Science Tools: State of the Key End Markets & the Outlook Ahead
